IDWeek 2024

IDWeek 2024

Huchet E, et al.

Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study

IDWeek24_P02_2024-10-08_v02
Video Player is loading.
Current Time 0:00
Duration 3:23
Loaded: 0%
Stream Type LIVE
Remaining Time 3:23
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Navigate to: